State senators have approved a bill to expand the business incubator at Farmingdale State College, a significant move aimed at boosting the local biotechnology sector. The legislation designates 38.5 acres for the Broad Hollow Bioscience Park and facilitates the construction of a third building to house start-up companies, with OSI Pharmaceuticals expanding into an existing second building. OSI, known for its lung cancer drug Tarceva, plans to create approximately 135 new jobs. The bill also exempts park tenants from state construction and procurement laws, simplifying development processes. This expansion is expected to drive economic growth and innovation in Long Island's biotechnology industry.
23
Mar
